PULMONARY EMBOLISM

Adverse reaction reported in 37,495 FDA reports across 29 drugs.

37,495
Total Reports
29
Drugs Involved
Drospirenone / Ethinyl Estradiol
Most Reported Drug

Drugs Associated with PULMONARY EMBOLISM

Drugs where "PULMONARY EMBOLISM" was reported as an adverse event.

# Drug Reports % of Total
1 Drospirenone / Ethinyl Estradiol 9,171
24.5%
2 Rivaroxaban 5,988
16.0%
3 Etonogestrel / Ethinyl Estradiol 3,951
10.5%
4 Testosterone 2,043
5.4%
5 Enoxaparin 1,795
4.8%
6 Apixaban 1,576
4.2%
7 Cisplatin 1,564
4.2%
8 Fluorouracil 1,387
3.7%
9 Fluorouracil Cream, 0.5% 1,383
3.7%
10 Gemcitabine 659
1.8%
11 Thalidomide 655
1.7%
12 Pemetrexed Disodium 645
1.7%
13 Ibuprofen / Diphenhydramine Citrate 588
1.6%
14 Dalteparin 584
1.6%
15 Testosterone Cypionate 555
1.5%
16 Medroxyprogesterone 481
1.3%
17 Heparin 478
1.3%
18 Leucovorin 444
1.2%
19 Fondaparinux 443
1.2%
20 Pemetrexed 436
1.2%
21 Temozolomide 419
1.1%
22 Canakinumab 387
1.0%
23 Conjugated Estrogens / Medroxyprogesterone Acetate 354
0.9%
24 Raloxifene 315
0.8%
25 Baricitinib 302
0.8%
26 Romiplostim 289
0.8%
27 Irinotecan 226
0.6%
28 Alteplase 192
0.5%
29 Tranexamic Acid 185
0.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused pulmonary embolism. Always consult your healthcare provider.